In 2023, the number of transluminal coronary angioplasties performed on in-patients in France stood at a notable level. As we move into the forecasted period, from 2024 through 2028, the procedures per hundred thousand persons are expected to increase consistently, with a steady year-on-year growth ranging from approximately 1.25% to 1.76%. The compound annual growth rate (CAGR) over this period suggests a robust upward trajectory, averaging a growth of about 1.53% annually.

Future trends to watch for include:

Technological advancements in medical procedures enhancing efficiency and outcomes.
Potential changes in healthcare policies affecting reimbursement rates and patient access.
Demographic shifts, such as an aging population, possibly increasing demand.
Increased public and private investment in healthcare infrastructure.